Effects of Competition on Drug-Product Selection
To the Editor: Three flaws in the study by Kralewski et al. (July 28 issue) 1 render its hypotheses questionable, reduce the internal and external validity, and do not permit the data to support the conclusions drawn. First of all, the study is based on the notion that pharmacists' drug-product...
Saved in:
Published in | The New England journal of medicine Vol. 309; no. 25; pp. 1585 - 1587 |
---|---|
Format | Journal Article |
Language | English |
Published |
United States
Massachusetts Medical Society
22.12.1983
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | To the Editor:
Three flaws in the study by Kralewski et al. (July 28 issue)
1
render its hypotheses questionable, reduce the internal and external validity, and do not permit the data to support the conclusions drawn.
First of all, the study is based on the notion that pharmacists' drug-product–selection behaviors can be explained by using two categories of drugs: "generic drug products" and "brand-name drug products." Such a classification is neither logical nor definitive. A useful classification, permitting meaningful comparisons, identifies each drug entity as containing single-source or multiple-source drug products. Single-source drug products are so classified because they are . . . |
---|---|
Bibliography: | SourceType-Other Sources-1 content type line 63 ObjectType-Correspondence-1 |
ISSN: | 0028-4793 1533-4406 |
DOI: | 10.1056/NEJM198312223092519 |